Qinghao Liu

Title: **Innovative Contributions of Qinghao Liu: A Patent Perspective**

Introduction

Qinghao Liu is a distinguished inventor based in Beijing, China, known for his significant contributions in the field of molecular biology and therapeutic innovations. With a total of three patents under his name, he has demonstrated a commitment to advancing medical treatments through innovative binding molecules.

Latest Patents

Among his notable patents, two stand out for their potential impact on medical treatments. The first patent is titled **"Binding molecule specific for CD39 and use thereof."** This invention introduces a binding molecule, specifically an antibody that targets CD39, which is instrumental in inhibiting the activity of this enzyme. The application includes the antibody’s use in treating various diseases, alongside a nucleic acid molecule that encodes the antibody and methods for its production.

The second patent is the **"Binding molecule specific for LIF and use thereof."** Here, Liu has developed an isolated antibody or its antigen-binding fragment that interacts with LIF, effectively inhibiting its activity. This invention also outlines several therapeutic applications for the isolated antibody in disease treatment.

Career Highlights

Qinghao Liu's career is marked by his role at Jacobio Pharmaceuticals Co., Ltd., where he has played an integral part in developing innovative therapeutic solutions. His research has primarily focused on creating binding molecules that can significantly improve treatment options for diseases.

Collaborations

Throughout his career, Liu has collaborated with notable colleagues, including Wenlai Zhou and Haiyan Yang. Their collective efforts reflect a strong commitment to research and innovation, further enhancing the impact of their work in the field of biotechnology.

Conclusion

Qinghao Liu's dedication to inventing new therapeutic molecules has led to significant advancements in the medical field. His innovative patents serve as a testament to his expertise and commitment to improving health outcomes through scientific research. With ongoing collaborations and continued research, Liu is well-positioned to contribute further to advancements in medicine and biotechnology.